[HTML][HTML] Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells
… While our findings thus underscore the role of GLUT1-mediated glucose metabolism in
gefitinib resistance, it may be worth noting here that, consistent with a previous observation that …
gefitinib resistance, it may be worth noting here that, consistent with a previous observation that …
[HTML][HTML] Effect of ABCG2/BCRP expression on efflux and uptake of gefitinib in NSCLC cell lines
… drug transport systems, in particular inhibiting MPP, glucose … drug resistance by inhibiting
the transporter function of … we investigated whether gefitinib inhibited the transporter function of …
the transporter function of … we investigated whether gefitinib inhibited the transporter function of …
[HTML][HTML] Apigenin combined with gefitinib blocks autophagy flux and induces apoptotic cell death through inhibition of HIF-1α, c-Myc, p-EGFR, and glucose metabolism …
ZS Chen, D Tian, X Liao, Y Zhang, J Xiao… - Frontiers in …, 2019 - frontiersin.org
… In the current study, as shown in Figure 8, we show that a combination of apigenin +
gefitinib in EGFR-mutated, TKI-resistant NSCLC will induce metabolic stress and energetic …
gefitinib in EGFR-mutated, TKI-resistant NSCLC will induce metabolic stress and energetic …
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors
H Su, C Bodenstein, RA Dumont, Y Seimbille… - Clinical Cancer …, 2006 - AACR
… as models for gefitinib-sensitive and gefitinib-resistant cells. … Furthermore, gefitinib-resistant
cell lines did not show a … lines, gefitinib leads to the translocation of glucose transporters from …
cell lines did not show a … lines, gefitinib leads to the translocation of glucose transporters from …
[HTML][HTML] Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
L Wang, W Peng, T Wu, P Deng, YL Zhao - Cell death discovery, 2018 - nature.com
… However, gefitinib treatment only decreased the glutamine … level of glucose consumption
when treated with gefitinib, but the … not glucose metabolism, correlate with gefitinib resistance in …
when treated with gefitinib, but the … not glucose metabolism, correlate with gefitinib resistance in …
[HTML][HTML] Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma
CD Hudson, T Hagemann, SJ Mather, N Avril - Cell death & disease, 2014 - nature.com
… of glucose transporter-1 (Glut-1) transporters from cytosolic … that PDAC resistance to axitinib
results in increased glucose … MET amplification leads to gefitinib resistance in lung cancer …
results in increased glucose … MET amplification leads to gefitinib resistance in lung cancer …
[HTML][HTML] Gefitinib-mediated reactive oxygen specie (ROS) instigates mitochondrial dysfunction and drug resistance in lung cancer cells
… into cellular perturbations that accompany acquired gefitinib resistance in lung cancer cells.
… , we generated gefitinib-resistant H1650 clone by long-term, chronic culture under gefitinib …
… , we generated gefitinib-resistant H1650 clone by long-term, chronic culture under gefitinib …
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell …
NT Ihle, G Paine-Murrieta, MI Berggren, A Baker… - Molecular cancer …, 2005 - AACR
… gefitinib. We also report on the toxicity of long-term administration of PX-866, showing that it
increases blood glucose … transporter-4 to the plasma membrane (45). It has been suggested …
increases blood glucose … transporter-4 to the plasma membrane (45). It has been suggested …
PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism
H Lin, H Han, M Yang, Z Wen, Q Chen, Y Ma… - European Journal of …, 2023 - Elsevier
… gefitinib (IC 50 … to gefitinib. Collectively, these data demonstrate that E5, a dual inhibitor
of PKM2/PDK1, may be a promising adjunct to gefitinib in the treatment of EGFR-TKIs resistant …
of PKM2/PDK1, may be a promising adjunct to gefitinib in the treatment of EGFR-TKIs resistant …
Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters
K Kunimasa, T Nagano, Y Shimono, R Dokuni… - Cancer …, 2017 - Wiley Online Library
… A effectively suppressed gefitinib-resistant tumor growth. … gefitinib-induced DTPs by exposing
PC9 cells to gefitinib (2 μM… showed upregulation of the glucose transporters Glut1 and Glut3…
PC9 cells to gefitinib (2 μM… showed upregulation of the glucose transporters Glut1 and Glut3…
相关搜索
- lung cancer cells gefitinib resistance
- cell death gefitinib resistance
- sijunzi tang gefitinib resistance
- abcg2 multidrug transporter egfr inhibitors gefitinib
- gefitinib in nsclc acquired resistance
- glucose transport and metabolism gefitinib resistance
- egfr t790m mutation gefitinib resistance
- erk phosphorylation gefitinib resistance
- glutamine metabolism gefitinib resistance
- autophagic degradation of egfr gefitinib resistance
- akt activation gefitinib resistance
- erk reactivation gefitinib resistance
- cancer drug resistance egfr inhibitors gefitinib
- non-small cell lung cancer gefitinib resistance